Soligenix announces recent accomplishments and third quarter 2022 financial results

Princeton, n.j. , nov. 10, 2022 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the quarter ended september 30, 2022.
SNGX Ratings Summary
SNGX Quant Ranking